Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen Concentrate vs Cryoprecipitate in Infants Undergoing Cardiac Surgery
NCT03014700Phase 4Completed
- Sponsor
- Stanford University
- Start
- Mar 2016
- Primary completion
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Fibrinogen human in acquired hypofibrinogenemia and postoperative hemorrhage (2 arms), sponsored by Stanford University. Primary endpoint: Total Units of Intraoperative Allogenic Donor Transfusions (ADT) Administered During Procedure Through ICU Arrival up to 24 hours. Started Mar 2016; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
acquired hypofibrinogenemiapostoperative hemorrhage
Beyond the preview
Go deeper on NCT03014700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03014700.